Try our Advanced Search for more refined results

Expert Analysis

Following Follow-On Biologics Legislation

Law360, New York (May 31, 2011, 4:24 PM EDT) -- The recently passed Biologics Price Competition and Innovation Act (BPCIA) is the first attempt to provide an abbreviated pathway for U.S. Food and Drug Administration approval for biological products that are biosimilar or interchangeable with a previously FDA-approved biologic product, in an effort to increase the presence of follow-on biologics in the marketplace. Although still in its infancy, the field of follow-on biologics is expected to have a significant impact on the biotech/pharma landscape....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!